Trial Profile
Phase IV trial of bupivacaine liposome injectable suspension (EXPAREL) in patients who underwent hip or knee arthroplasty
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2015
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary) ; Bupivacaine; Ketorolac; Morphine
- Indications Postoperative pain
- Focus Therapeutic Use
- 31 Mar 2015 New trial record
- 26 Mar 2015 Primary endpoint (Percent of VAS pain scores that were 0) has been met, according to Pacira Pharmaceuticals media release.
- 26 Mar 2015 Primary endpoint (Visual Analog Scale (VAS) pain scores) has been met, according to Pacira Pharmaceuticals media release.